Clinical Benefit of Topoisomerase Downregulation
NCT00250094
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
DRUG:
Topotecan and VP16
Sponsor
New Mexico Cancer Research Alliance